Replies to post #345799 on Amarin Corp Plc (AMRN)

[AMRNEPA]

Raf - thanks for posting !

[fsulevine]

Thanks raf. One question. Are there ways to access weekly prescriptions from other countries? Especially once we launch in the E.U.?

[MNBioMike]

Nice to see all of the pandemic pent up Vascepa demand coming thru. We’re really outpacing generics as Thero mentioned.

Meanwhile Yee’s response is playing over and over in my head…..”Wow….Okay”

[iwishiknew]

Raf - Error for 6/25 Vascepa Rx numbers

The numbers for TRx should equal NRx + Ref. They don't. Can you please check and correct?
Thanks for your work.

[rafunrafun]

Scripts for week ending July 2, 2021.

Overall drug TRx are +0.8% w/w.

Vascepa
TRx 84,187; +1.1% (+936) w/w; +0.1% y/y
NRx 37,629; +2.1% (+765) w/w; -0.2% y/y
Ref 46,558; +0.4% (+171) w/w; +0.4% y/y

Lovaza (Generic & Brand)
TRx 63,472; +1.3% (+828) w/w; +6.3% y/y
NRx 31,100; +1.1% (+338) w/w; +10.3% y/y
Ref 32,371; +1.5% (+491) w/w; +2.7% y/y

Generic Vascepa
TRx 13,434; -4.0% (-562)w/w; As % of total V: 13.8%
NRx 7,803; +0.0% (+1) w/w; As % of total V: 17.2%
Ref 5,631; -9.1% (-563) w/w; As % of total V: 10.8%

Generic Vascepa by Manufacturer
Hikma TRx 11,608; Generic share 86.4%; Total V share 11.9%
Reddy TRx 1,826; Generic share 13.6%; Total V share 1.9%